Viewing Study NCT01995058


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2025-12-31 @ 10:11 PM
Study NCT ID: NCT01995058
Status: TERMINATED
Last Update Posted: 2015-02-20
First Post: 2013-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Sponsor: Exelixis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module